BeyondSpring Inc. SEC filings BYSI
BeyondSpring Inc. has 264 filings in SEC EDGAR's recent list, going back to Jun 30, 2016. Its latest annual report, Form ARS, was filed on Sep 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 13, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Sep 29, 2026 | — |
| 424B5 | Prospectus supplement | Nov 17, 2025 | — |
| POS AM | Filing | Aug 13, 2025 | — |
| F-3/A | Filing | Jul 2, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Jun 12, 2024 | — |
| 424B5 | Prospectus supplement | Jun 12, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Jul 2, 2021 | — |
| 424B5 | Prospectus supplement | Nov 19, 2020 | — |
| 424B5 | Prospectus supplement | Nov 17, 2020 | — |
| F-3 | Shelf registration (foreign issuer) | Nov 3, 2020 | — |
| S-8 | Employee stock plan registration | Jul 24, 2020 | — |
| 424B5 | Prospectus supplement | Jun 19, 2020 | — |
| 424B5 | Prospectus supplement | Jun 18, 2020 | — |
| 424B5 | Prospectus supplement | Feb 7, 2020 | — |
| 424B5 | Prospectus supplement | Oct 28, 2019 | — |
| 424B5 | Prospectus supplement | Oct 25, 2019 | — |
| F-3 | Shelf registration (foreign issuer) | Oct 15, 2019 | — |
| 424B5 | Prospectus supplement | Jul 18, 2019 | — |
| 424B5 | Prospectus supplement | Jul 16, 2019 | — |
| 424B5 | Prospectus supplement | May 21, 2019 | — |
| 424B5 | Prospectus supplement | May 29, 2018 | — |
| F-3 | Shelf registration (foreign issuer) | Apr 25, 2018 | — |
| S-8 | Employee stock plan registration | Mar 13, 2017 | — |
| 424B4 | Prospectus | Mar 9, 2017 | — |
| F-1MEF | Filing | Mar 8, 2017 | — |
| F-1/A | Filing | Mar 8, 2017 | — |
| F-1/A | Filing | Mar 2, 2017 | — |
| FWP | Free writing prospectus | Feb 28, 2017 | — |
| F-1/A | Filing | Feb 28, 2017 | — |
| F-1/A | Filing | Feb 7, 2017 | — |
| F-1 | Registration statement (foreign issuer) | Nov 15, 2016 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BYSI (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Florham Park, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1677940
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.